J.P. Morgan Notebook Day 1: Tax Reform At Last, Allergan's Job Cuts, Teva Turnaround, Biogen's Cash, And Getting FDA-Friendly

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.